Search research articles
Contact Us
Filters
Showing results (11-20 of 180) with videos related to
Page
of 18
Sort By:
International Journal of Cancer
|
September 2, 1999
Molecular effects of paclitaxel: myths and reality (a critical review)
M V Blagosklonny, T Fojo
Journal of Chemotherapy (Florence, Italy)
|
February 4, 2005
Platinums: extending their therapeutic spectrum
F M Muggia, T Fojo
Cancer Research
|
November 26, 1997
Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype
Y Matsumoto, H Takano, T Fojo
Journal of the National Cancer Institute
|
February 3, 2000
Tubulin/microtubules: still a promising target for new chemotherapeutic agents
P Giannakakou, D Sackett, T Fojo
The Journal of Clinical Endocrinology and Metabolism
|
January 14, 2000
Construction of gene therapy vectors targeting adrenocortical cells: enhancement of activity and specificity with agents modulating the cyclic adenosine 3',5'-monophosphate pathway
Y Chuman, Z Zhan, T Fojo
Biochemical and Biophysical Research Communications
|
October 30, 1998
Limitations of differential display
P Ledakis, H Tanimura, T Fojo
The Lancet. Public Health
|
December 19, 2017
Multidrug-resistant tuberculosis in India: looking back, thinking ahead
Anthony T Fojo, David W Dowdy
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 15, 2019
Ending the Human Immunodeficiency Virus Epidemic: Towards an Evidence-Based Approach
Anthony T Fojo, David W Dowdy
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
November 10, 2006
Future perspectives for the development of P-glycoprotein modulators
V Sandor, T Fojo, S E Bates
Annals of Internal Medicine
|
August 6, 2000
Radiofrequency ablation of metastatic lesions in adrenocortical cancer
J Abraham, T Fojo, B J Wood
Page
of 18
Search research articles
Search
Showing results (11-20 of 180) with videos related to
Sort By:
Page
of 18
International Journal of Cancer
|
September 2, 1999
Molecular effects of paclitaxel: myths and reality (a critical review)
M V Blagosklonny, T Fojo
Journal of Chemotherapy (Florence, Italy)
|
February 4, 2005
Platinums: extending their therapeutic spectrum
F M Muggia, T Fojo
Cancer Research
|
November 26, 1997
Cellular adaptation to drug exposure: evolution of the drug-resistant phenotype
Y Matsumoto, H Takano, T Fojo
Journal of the National Cancer Institute
|
February 3, 2000
Tubulin/microtubules: still a promising target for new chemotherapeutic agents
P Giannakakou, D Sackett, T Fojo
The Journal of Clinical Endocrinology and Metabolism
|
January 14, 2000
Construction of gene therapy vectors targeting adrenocortical cells: enhancement of activity and specificity with agents modulating the cyclic adenosine 3',5'-monophosphate pathway
Y Chuman, Z Zhan, T Fojo
Biochemical and Biophysical Research Communications
|
October 30, 1998
Limitations of differential display
P Ledakis, H Tanimura, T Fojo
The Lancet. Public Health
|
December 19, 2017
Multidrug-resistant tuberculosis in India: looking back, thinking ahead
Anthony T Fojo, David W Dowdy
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
October 15, 2019
Ending the Human Immunodeficiency Virus Epidemic: Towards an Evidence-Based Approach
Anthony T Fojo, David W Dowdy
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
November 10, 2006
Future perspectives for the development of P-glycoprotein modulators
V Sandor, T Fojo, S E Bates
Annals of Internal Medicine
|
August 6, 2000
Radiofrequency ablation of metastatic lesions in adrenocortical cancer
J Abraham, T Fojo, B J Wood
Page
of 18